查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1810899

2025年全球基因编辑转染化学品市场报告

Gene-Editing Transfection Chemicals Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基因编辑转染化学品市场将强劲成长，2029年将达到14.5亿美元，复合年增长率为7.8%。预测期内的成长将由以下因素推动：基因编辑在临床护理中的应用不断扩展、生物技术和製药行业投资的增加、对非病毒递送方法的需求不断增长、罕见病和遗传病发病率的上升、全球对个性化医疗的关注以及再生医学的进步。预计影响这一时期的主要趋势包括：向奈米颗粒和脂质递送系统的转变、自动化和高性能技术的采用、微流体和单细胞递送技术的兴起、奈米技术的整合以及核壳二氧化硅奈米颗粒平台的开发。

基因治疗研究的加速发展预计将在未来几年推动基因治疗市场的成长。基因治疗是一种透过直接修改或纠正个别细胞中的缺陷基因来治疗或预防疾病的技术。基因治疗的进步得益于 CRISPR 等基因编辑技术的突破，这些技术使科学家能够精确定位和修改导致遗传疾病的缺陷基因。基因编辑转染化学物质在基因治疗研发中发挥关键作用，它们能够将遗传物质（如 CRISPR-Cas9 组件、mRNA 和质体DNA）有效地递送到人体细胞中。例如，2024 年 8 月，瑞士保险公司 PartnerRe 报告称，FDA 预计在 2023 年底前核准7 种基因疗法，并在 2024 年创下新纪录，今年上半年将再核准7 种基因疗法。目前，有超过 500 种基因疗法正在开发中，FDA 预测到 2025 年将核准另外 10 到 20 种基因和细胞疗法。因此，基因治疗的快速发展正在推动用于基因编辑的转染化学品市场的不断扩大。

基因编辑转染化学品市场的主要企业正致力于推出创新解决方案，例如脂质奈米颗粒 (LNP) 入门套件，以简化基因治疗和 mRNA 递送过程。脂质奈米颗粒 (LNP) 入门套件是即用型配方或套件，包含预先优化的脂质成分和通讯协定，旨在帮助开发和测试基于 LNP 的递送系统。例如，瑞士製药公司 Corden Pharma 于 2024 年 2 月推出了其脂质奈米颗粒 (LNP) 入门套件，旨在支持基于 mRNA 的疗法（包括疫苗和基因疗法）的配方和优化研发。这些套件包含四种必需脂质——可电离脂质、辅助脂质、固醇和聚乙二醇化脂质——并使用商业规模的高纯度材料，以确保批次间的一致性并最大限度地降低开发过程中宝贵的有效载荷损失的风险。透过提供可靠且可扩展的脂质平台，Corden Pharma 旨在加速基因编辑和 mRNA 疗法的发展，同时保护宝贵的基因负荷。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基因编辑转染化学品：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球基因编辑转染化学品市场：成长率分析
  • 全球基因编辑转染化学品市场表现：规模与成长，2019-2024
  • 全球基因编辑转染化学品市场预测：规模与成长，2024-2029，2034
  • 全球基因编辑转染化学品：总潜在市场（TAM）

第六章 市场细分

  • 全球基因编辑转染化学品市场（按化学品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 脂质基
  • 聚合物基
  • 基于胜肽
  • 其他化学类型
  • 全球基因编辑转染化学品市场（按感染机制、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 非病毒
  • 病毒性的
  • 全球基因编辑转染化学品市场的应用、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 生物医学研究
  • 药物研发
  • 疾病模型
  • 农业生物技术
  • 疫苗研发
  • 其他的
  • 全球基因编辑转染化学品市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 学术研究机构
  • 生技公司
  • 製药公司
  • 其他的
  • 全球基因编辑转染化学品市场：基于脂质的细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 阳离子脂质
  • 中性脂质
  • 离子化脂质
  • 全球基因编辑转染化学品市场：基于聚合物的细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚乙烯亚胺（PEI）
  • 聚（L-离胺酸）（PLL）
  • 树状聚合物
  • 全球基因编辑转染化学品市场：基于胜肽的细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞穿透胜肽（CPP）
  • 双亲性肽
  • 目标胜肽
  • 全球基因编辑转染化学品市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 无机奈米粒子
  • 混合奈米粒子

第七章 区域和国家分析

  • 全球基因编辑转染化学品市场：依地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球基因编辑转染化学品市场：依国家、绩效及预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基因编辑转染化学品市场：竞争格局
  • 基因编辑转染化学品市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies Inc.
    • Lonza Group AG
    • Sartorius AG

第31章：其他领先和创新企业

  • Bio-Rad Laboratories Inc.
  • Takara Bio Inc.
  • GenScript BIoTech Corporation
  • Integrated DNA Technologies Inc.
  • Promega Corporation
  • Eurogentec SA
  • Horizon Discovery Group plc
  • OriGene Technologies Inc.
  • Enzo Life Sciences Inc.
  • Apollo Scientific Ltd.
  • Mirus Bio LLC
  • OZ Biosciences SAS
  • Genlantis Inc.
  • Polyplus-Transfection SA
  • Altogen Biosystems LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年基因编辑转染化学品市场：提供新机会的国家
  • 2029年基因编辑转染化学品市场：细分领域带来新机会
  • 2029年基因编辑转染化学品市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r36999

Gene-editing transfection chemicals are specially designed substances that enable the efficient transfer of gene-editing tools like CRISPR-Cas9 complexes, plasmid DNA, or RNA molecules into living cells by helping them cross the cell membrane intact. These agents are vital for achieving high transfection efficiency and successful genome editing because they safeguard the genetic material and support its uptake, expression, and function within the target cells.

The primary types of gene-editing transfection chemicals include lipid-based, polymer-based, peptide-based, and others. Lipid-based transfection agents consist of lipid molecules that assist in delivering gene-editing tools such as CRISPR-Cas9 into cells. These chemicals use various delivery strategies, including both viral and non-viral methods, and have applications across biomedical research, drug discovery, disease modeling, agricultural biotechnology, vaccine development, and more. Their main users are academic and research institutions, biotechnology firms, pharmaceutical companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The gene-editing transfection chemicals market research report is one of a series of new reports from The Business Research Company that provides gene-editing transfection chemicals market statistics, including gene-editing transfection chemicals industry global market size, regional shares, competitors with a gene-editing transfection chemicals market share, detailed gene-editing transfection chemicals market segments, market trends and opportunities, and any further data you may need to thrive in the gene-editing transfection chemicals industry. This gene-editing transfection chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene-editing transfection chemicals market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The expansion during the historic period was driven by the early implementation of CRISPR-Cas9 technology, increased emphasis on cancer and genetic disorder studies, initial demand from academic and research organizations, the accessibility of fundamental chemical transfection reagents, and the swift advancement of cell biology and molecular diagnostics.

The gene-editing transfection chemicals market size is expected to see strong growth in the next few years. It will grow to $1.45 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth during the forecast period is driven by the expanding application of gene editing in clinical therapies, increased investments from biotech and pharmaceutical sectors, rising demand for non-viral delivery methods, growing incidence of rare and inherited diseases, worldwide focus on personalized medicine, and the advancement of regenerative treatments. Key trends expected to shape this period include a move toward nanoparticle and lipid-based delivery systems, the adoption of automation and high-throughput technologies, the rise of microfluidic and single-cell delivery techniques, integration of nanotechnology, and the development of core-shell silica nanoparticle platforms.

The accelerated research in gene therapy is anticipated to drive the growth of the gene-editing transfection chemicals market in the coming years. Gene therapy is a technique aimed at treating or preventing diseases by directly modifying or correcting defective genes within an individual's cells. Progress in gene therapy is speeding up due to breakthroughs in gene-editing technologies like CRISPR, which allow scientists to accurately target and alter faulty genes responsible for genetic disorders. Gene-editing transfection chemicals play a crucial role in gene therapy research and development by enabling the efficient delivery of genetic materials such as CRISPR-Cas9 components, mRNA, and plasmid DNA into human cells. For example, in August 2024, PartnerRe, a Switzerland-based insurance company, reported that by the end of 2023, the FDA had approved 7 gene therapies, with 2024 expected to set a new record by approving seven more within the first half of the year. Currently, over 500 gene therapies are in development, and the FDA is projected to approve an additional 10 to 20 gene and cell therapies by 2025. Consequently, the rapid advancements in gene therapy are fueling the expansion of the gene-editing transfection chemicals market.

Leading companies in the gene-editing transfection chemicals market are concentrating on launching innovative solutions, such as lipid nanoparticle (LNP) starter kits, to simplify gene therapy and mRNA delivery processes. Lipid nanoparticle (LNP) starter kits are ready-to-use formulations or toolkits that include pre-optimized lipid components and protocols designed to aid in the development and testing of LNP-based delivery systems. For instance, in February 2024, CordenPharma, a Switzerland-based pharmaceutical firm, introduced Lipid NanoParticle (LNP) Starter Kits intended to assist researchers and developers in formulating and optimizing mRNA-based therapeutics, including vaccines and gene therapies. These kits feature four essential lipids - ionizable lipids, helper lipids, sterols, and PEGylated lipids - sourced from commercial-scale, high-purity materials to ensure consistency between batches and minimize the risk of losing valuable payloads during development. By offering a dependable and scalable lipid platform, CordenPharma aims to speed up the development of gene editing and mRNA therapeutics while protecting high-value genetic payloads.

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio LLC for $600 million. Through this acquisition, Merck seeks to enhance its goal of providing fully integrated and comprehensive solutions for all stages of viral vector manufacturing, supporting the development and commercialization of cell and gene therapies from preclinical research through to commercial production. Mirus Bio LLC, based in the US, produces transfection reagents used in gene editing and other cell and gene therapy applications.

Major players in the gene-editing transfection chemicals market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Bio-Rad Laboratories Inc., Takara Bio Inc., GenScript Biotech Corporation, Integrated DNA Technologies Inc., Promega Corporation, Eurogentec S.A., Horizon Discovery Group plc, OriGene Technologies Inc., Enzo Life Sciences Inc., Apollo Scientific Ltd., Mirus Bio LLC, OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, Canvax Biotech S.L., EZ Biosystems LLC, and SignaGen Laboratories.

North America was the largest region in the gene-editing transfection chemicals market in 2024. The regions covered in gene-editing transfection chemicals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene-editing transfection chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene-editing transfection chemicals market consists of sales of products, including lipid-based transfection reagents, polymer-based transfection reagents, electroporation buffers and kits, nanoparticle-based delivery systems, and cell-specific transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene-Editing Transfection Chemicals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene-editing transfection chemicals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene-editing transfection chemicals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene-editing transfection chemicals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Chemical Type: Lipid-Based; Polymer-Based; Peptide-Based; Other Chemical Types
  • 2) By Delivery Mechanism: Non-Viral; Viral
  • 3) By Application: Biomedical Research; Drug Discovery; Disease Modeling; Agricultural Biotechnology; Vaccine Development; Other Applications
  • 4) By End-User: Academic And Research Institutes; Biotechnology Companies; Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Lipid-Based: Cationic Lipids; Neutral Lipids; Ionizable Lipids
  • 2) By Polymer-Based: Polyethyleneimine (PEI); Poly(L-Lysine) (PLL); Dendrimers
  • 3) By Peptide-Based: Cell-Penetrating Peptides (CPPs); Amphipathic Peptides; Targeting Peptides
  • 4) By Other Chemical Types: Inorganic Nanoparticles; Hybrid Nanoparticles
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; Lonza Group AG; Sartorius AG; Bio-Rad Laboratories Inc.; Takara Bio Inc.; GenScript Biotech Corporation; Integrated DNA Technologies Inc.; Promega Corporation; Eurogentec S.A.; Horizon Discovery Group plc; OriGene Technologies Inc.; Enzo Life Sciences Inc.; Apollo Scientific Ltd.; Mirus Bio LLC; OZ Biosciences SAS; Genlantis Inc.; Polyplus-Transfection SA; Altogen Biosystems LLC; Canvax Biotech S.L.; EZ Biosystems LLC; SignaGen Laboratories.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene-Editing Transfection Chemicals Market Characteristics

3. Gene-Editing Transfection Chemicals Market Trends And Strategies

4. Gene-Editing Transfection Chemicals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gene-Editing Transfection Chemicals Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gene-Editing Transfection Chemicals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gene-Editing Transfection Chemicals Market Growth Rate Analysis
  • 5.4. Global Gene-Editing Transfection Chemicals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gene-Editing Transfection Chemicals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gene-Editing Transfection Chemicals Total Addressable Market (TAM)

6. Gene-Editing Transfection Chemicals Market Segmentation

  • 6.1. Global Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lipid-Based
  • Polymer-Based
  • Peptide-Based
  • Other Chemical Types
  • 6.2. Global Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Viral
  • Viral
  • 6.3. Global Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biomedical Research
  • Drug Discovery
  • Disease Modeling
  • Agricultural Biotechnology
  • Vaccine Development
  • Other Applications
  • 6.4. Global Gene-Editing Transfection Chemicals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Other End-Users
  • 6.5. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Lipid-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cationic Lipids
  • Neutral Lipids
  • Ionizable Lipids
  • 6.6. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polyethyleneimine (PEI)
  • Poly(L-lysine) (PLL)
  • Dendrimers
  • 6.7. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Peptide-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell-Penetrating Peptides (CPPs)
  • Amphipathic Peptides
  • Targeting Peptides
  • 6.8. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Other Chemical Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inorganic Nanoparticles
  • Hybrid Nanoparticles

7. Gene-Editing Transfection Chemicals Market Regional And Country Analysis

  • 7.1. Global Gene-Editing Transfection Chemicals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gene-Editing Transfection Chemicals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene-Editing Transfection Chemicals Market

  • 8.1. Asia-Pacific Gene-Editing Transfection Chemicals Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene-Editing Transfection Chemicals Market

  • 9.1. China Gene-Editing Transfection Chemicals Market Overview
  • 9.2. China Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene-Editing Transfection Chemicals Market

  • 10.1. India Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene-Editing Transfection Chemicals Market

  • 11.1. Japan Gene-Editing Transfection Chemicals Market Overview
  • 11.2. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene-Editing Transfection Chemicals Market

  • 12.1. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene-Editing Transfection Chemicals Market

  • 13.1. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene-Editing Transfection Chemicals Market

  • 14.1. South Korea Gene-Editing Transfection Chemicals Market Overview
  • 14.2. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene-Editing Transfection Chemicals Market

  • 15.1. Western Europe Gene-Editing Transfection Chemicals Market Overview
  • 15.2. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene-Editing Transfection Chemicals Market

  • 16.1. UK Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene-Editing Transfection Chemicals Market

  • 17.1. Germany Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene-Editing Transfection Chemicals Market

  • 18.1. France Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene-Editing Transfection Chemicals Market

  • 19.1. Italy Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene-Editing Transfection Chemicals Market

  • 20.1. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene-Editing Transfection Chemicals Market

  • 21.1. Eastern Europe Gene-Editing Transfection Chemicals Market Overview
  • 21.2. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene-Editing Transfection Chemicals Market

  • 22.1. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene-Editing Transfection Chemicals Market

  • 23.1. North America Gene-Editing Transfection Chemicals Market Overview
  • 23.2. North America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene-Editing Transfection Chemicals Market

  • 24.1. USA Gene-Editing Transfection Chemicals Market Overview
  • 24.2. USA Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene-Editing Transfection Chemicals Market

  • 25.1. Canada Gene-Editing Transfection Chemicals Market Overview
  • 25.2. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene-Editing Transfection Chemicals Market

  • 26.1. South America Gene-Editing Transfection Chemicals Market Overview
  • 26.2. South America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene-Editing Transfection Chemicals Market

  • 27.1. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene-Editing Transfection Chemicals Market

  • 28.1. Middle East Gene-Editing Transfection Chemicals Market Overview
  • 28.2. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene-Editing Transfection Chemicals Market

  • 29.1. Africa Gene-Editing Transfection Chemicals Market Overview
  • 29.2. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene-Editing Transfection Chemicals Market Competitive Landscape And Company Profiles

  • 30.1. Gene-Editing Transfection Chemicals Market Competitive Landscape
  • 30.2. Gene-Editing Transfection Chemicals Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Gene-Editing Transfection Chemicals Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Takara Bio Inc.
  • 31.3. GenScript Biotech Corporation
  • 31.4. Integrated DNA Technologies Inc.
  • 31.5. Promega Corporation
  • 31.6. Eurogentec S.A.
  • 31.7. Horizon Discovery Group plc
  • 31.8. OriGene Technologies Inc.
  • 31.9. Enzo Life Sciences Inc.
  • 31.10. Apollo Scientific Ltd.
  • 31.11. Mirus Bio LLC
  • 31.12. OZ Biosciences SAS
  • 31.13. Genlantis Inc.
  • 31.14. Polyplus-Transfection SA
  • 31.15. Altogen Biosystems LLC

32. Global Gene-Editing Transfection Chemicals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene-Editing Transfection Chemicals Market

34. Recent Developments In The Gene-Editing Transfection Chemicals Market

35. Gene-Editing Transfection Chemicals Market High Potential Countries, Segments and Strategies

  • 35.1 Gene-Editing Transfection Chemicals Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gene-Editing Transfection Chemicals Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gene-Editing Transfection Chemicals Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer